HomePGEN • NASDAQ
add
Precigen Inc
Previous close
$3.74
Day range
$3.72 - $3.92
Year range
$0.65 - $5.23
Market cap
1.36B USD
Avg Volume
4.81M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 2.92M | 206.61% |
Operating expense | 23.99M | 143.91% |
Net income | -146.34M | -510.33% |
Net profit margin | -5.01K | -99.06% |
Earnings per share | — | — |
EBITDA | -33.68M | -63.58% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 121.14M | 323.09% |
Total assets | 171.26M | 105.17% |
Total liabilities | 129.40M | 360.52% |
Total equity | 41.87M | — |
Shares outstanding | 353.82M | — |
Price to book | 31.17 | — |
Return on assets | -63.11% | — |
Return on capital | -123.75% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -146.34M | -510.33% |
Cash from operations | -29.07M | -27.87% |
Cash from investing | -63.39M | -1,221.28% |
Cash from financing | 93.01M | 189.50% |
Net change in cash | 562.00K | -96.28% |
Free cash flow | -14.02M | 4.42% |
About
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
Founded
May 21, 1998
Website
Employees
143
